US Patent Issued to Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical on March 25 for "CD3 antibody and pharmaceutical use thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,405, issued on March 25, was assigned to Jiangsu Hengrui Medicine Co. Ltd. (Jiangsu, China) and Shanghai Hengrui Pharmaceutical Co. Ltd. (Shanghai).

"CD3 antibody and pharmaceutical use thereof" was invented by Hua Ying (Shanghai), Ling Zhang (Shanghai), Xiaoying Yang (Shanghai), Hu Ge (Shanghai) and Weikang Tao (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a CD3 antibody and a pharmaceutical use thereof. Specifically, the present disclosure relates to forming a multi-specificity antibody by using CD3 antibody and binding molecules of another target. The multi-specificity antibody may simultaneously bind...